Richard L. Lindstrom MD - 24 Sep 2021 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)

Role
Director
Signature
/s/ Richard L. Lindstrom
Issuer symbol
HROW
Transactions as of
24 Sep 2021
Net transactions value
-$39,156
Form type
4
Filing time
27 Sep 2021, 19:31:42 UTC
Previous filing
17 Sep 2021
Next filing
16 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HROW Common Stock Sale $39,156 -3,900 -5.6% $10.04 66,100 24 Sep 2021 See Footnote F1, F2, F3
holding HROW Common Stock 100,000 24 Sep 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2021 and was terminated by the reporting person on September 24, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.01 to $10.08, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. ("Harrow"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Represents shares held by the Lindstrom Family Limited Partnership No. 2, a limited partnership of which the reporting person is the general partner.

Remarks:

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).